Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher A Miller

Showing results (101-110 of 235) with videos related to

Pageof 24
Sort By:
Cancer Immunology Research|November 2, 2016
Endogenous Neoantigen-Specific CD8 T Cells Identified in Two Glioblastoma Models Using a Cancer Immunogenomics ApproachTanner M Johanns, Jeffrey P Ward, Christopher A Miller, et al.
Journal of the American College of Cardiology|September 1, 2022
Validated Model for Prediction of Adverse Cardiac Outcome in Patients With Fabry DiseaseChristopher Orsborne, Joshua Bradley, Laura J Bonnett, et al.
Oncotarget|February 10, 2018
Clinical outcomes and differential effects of PI3K pathway mutation in obese versus non-obese patients with cervical cancerPerry Grigsby, Adnan Elhammali, Fiona Ruiz, et al.
The Journal of Molecular Diagnostics : JMD|January 18, 2022
Failure to Detect Mutations in U2AF1 due to Changes in the GRCh38 Reference SequenceChristopher A Miller, Jason R Walker, Travis L Jensen, et al.
Cold Spring Harbor Molecular Case Studies|May 6, 2016
A common founding clone with TP53 and PTEN mutations gives rise to a concurrent germ cell tumor and acute megakaryoblastic leukemiaCharles Lu, Peter Riedell, Christopher A Miller, et al.
Cancer Cell|March 25, 2014
The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramersDavid A Russler-Germain, David H Spencer, Margaret A Young, et al.
Heart (British Cardiac Society)|August 11, 2023
Growth differentiation factor-15 in patients with or at risk of heart failure but before first hospitalisationJoshua Bradley, Erik B Schelbert, Laura J Bonnett, et al.
Brain Pathology (Zurich, Switzerland)|February 3, 2016
ATRX in Diffuse Gliomas With its Mosaic/Heterogeneous Expression in a SubsetSuvendu Purkait, Christopher A Miller, Anupam Kumar, et al.
JACC. Cardiovascular Imaging|May 20, 2019
Extracellular Volume Associates With Outcomes More Strongly Than Native or Post-Contrast Myocardial T1Thomas A Treibel, Yaron Fridman, Patrick Bering, et al.
The Journal of Clinical Investigation|December 7, 2023
Proteogenomic analysis reveals cytoplasmic sequestration of RUNX1 by the acute myeloid leukemia-initiating CBFB::MYH11 oncofusion proteinRyan B Day, Julia A Hickman, Ziheng Xu, et al.
Pageof 24

Showing results (101-110 of 235) with videos related to

Sort By:
Pageof 24
Cancer Immunology Research|November 2, 2016
Endogenous Neoantigen-Specific CD8 T Cells Identified in Two Glioblastoma Models Using a Cancer Immunogenomics ApproachTanner M Johanns, Jeffrey P Ward, Christopher A Miller, et al.
Journal of the American College of Cardiology|September 1, 2022
Validated Model for Prediction of Adverse Cardiac Outcome in Patients With Fabry DiseaseChristopher Orsborne, Joshua Bradley, Laura J Bonnett, et al.
Oncotarget|February 10, 2018
Clinical outcomes and differential effects of PI3K pathway mutation in obese versus non-obese patients with cervical cancerPerry Grigsby, Adnan Elhammali, Fiona Ruiz, et al.
The Journal of Molecular Diagnostics : JMD|January 18, 2022
Failure to Detect Mutations in U2AF1 due to Changes in the GRCh38 Reference SequenceChristopher A Miller, Jason R Walker, Travis L Jensen, et al.
Cold Spring Harbor Molecular Case Studies|May 6, 2016
A common founding clone with TP53 and PTEN mutations gives rise to a concurrent germ cell tumor and acute megakaryoblastic leukemiaCharles Lu, Peter Riedell, Christopher A Miller, et al.
Cancer Cell|March 25, 2014
The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramersDavid A Russler-Germain, David H Spencer, Margaret A Young, et al.
Heart (British Cardiac Society)|August 11, 2023
Growth differentiation factor-15 in patients with or at risk of heart failure but before first hospitalisationJoshua Bradley, Erik B Schelbert, Laura J Bonnett, et al.
Brain Pathology (Zurich, Switzerland)|February 3, 2016
ATRX in Diffuse Gliomas With its Mosaic/Heterogeneous Expression in a SubsetSuvendu Purkait, Christopher A Miller, Anupam Kumar, et al.
JACC. Cardiovascular Imaging|May 20, 2019
Extracellular Volume Associates With Outcomes More Strongly Than Native or Post-Contrast Myocardial T1Thomas A Treibel, Yaron Fridman, Patrick Bering, et al.
The Journal of Clinical Investigation|December 7, 2023
Proteogenomic analysis reveals cytoplasmic sequestration of RUNX1 by the acute myeloid leukemia-initiating CBFB::MYH11 oncofusion proteinRyan B Day, Julia A Hickman, Ziheng Xu, et al.
Pageof 24